<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>GMA Weekly Intelligence · English</title><link>https://gmafoodintelligence.it/en/latest/</link><description>Weekly nutraceutical news, food supplement intelligence and applied AI.</description><language>en-GB</language><lastBuildDate>Mon, 03 Aug 2026 06:00:00 GMT</lastBuildDate><item><title>GeNeurofil™ and cognitive decline: a clinical signal that needs confirmation.</title><link>https://gmafoodintelligence.it/en/news/2026/08/03/geneurofil-cognitive-decline-pilot-trial-biomarkers/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/03/geneurofil-cognitive-decline-pilot-trial-biomarkers/</guid><pubDate>Mon, 03 Aug 2026 06:00:00 GMT</pubDate><description>A six-month randomised, double-blind, placebo-controlled pilot trial assessed GeNeurofil™ in 54 people with mild-to-moderate cognitive impairment.</description></item><item><title>Probiotics and weight cutting: what the new trial teaches developers.</title><link>https://gmafoodintelligence.it/en/news/2026/08/03/probiotics-weight-cutting-athletes-formulation-lessons/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/03/probiotics-weight-cutting-athletes-formulation-lessons/</guid><pubDate>Mon, 03 Aug 2026 06:00:00 GMT</pubDate><description>A randomised trial in 24 elite male athletes links a specific probiotic blend with intestinal markers, gastrointestinal symptoms and microbiota during pre-competition weight loss.</description></item><item><title>From paper to shortlist: how LLMs can accelerate strain scouting.</title><link>https://gmafoodintelligence.it/en/news/2026/08/03/llm-text-mining-workflow-nutraceutical-strain-scouting/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/03/llm-text-mining-workflow-nutraceutical-strain-scouting/</guid><pubDate>Mon, 03 Aug 2026 06:00:00 GMT</pubDate><description>A nutraceutical text-mining preprint becomes an operational case: extract strain-compound relationships, preserve provenance and prepare a verifiable R&amp;D shortlist.</description></item><item><title>Innovative botanicals: the challenge is moving from bioactivity to transferability.</title><link>https://gmafoodintelligence.it/en/news/2026/08/03/botanicals-functional-foods-characterisation-to-translation/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/03/botanicals-functional-foods-characterisation-to-translation/</guid><pubDate>Mon, 03 Aug 2026 06:00:00 GMT</pubDate><description>A Frontiers editorial connects eight studies on medicinal plants and fungi across chemical characterisation, mechanisms and translational assessment.</description></item><item><title>Multi-ingredient formulas: evidence is shifting towards the finished product.</title><link>https://gmafoodintelligence.it/en/news/2026/08/03/multi-ingredient-formulations-finished-product-validation/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/03/multi-ingredient-formulations-finished-product-validation/</guid><pubDate>Mon, 03 Aug 2026 06:00:00 GMT</pubDate><description>Recent work on greens powders, probiotic blends and complex nutraceutical concepts points to growing interest in validating the complete formulation.</description></item><item><title>Food additives: EFSA’s dossier architecture changed on 20 July.</title><link>https://gmafoodintelligence.it/en/news/2026/08/02/efsa-food-additive-guidance-dossiers-20-july-2026/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/02/efsa-food-additive-guidance-dossiers-20-july-2026/</guid><pubDate>Sun, 02 Aug 2026 06:00:00 GMT</pubDate><description>New applications must follow updated requirements for identity, stability, dietary exposure, genotoxicity and environmental safety assessment.</description></item><item><title>L-α-GPC: EFSA opens a regulatory route, not a cognitive claim.</title><link>https://gmafoodintelligence.it/en/news/2026/08/02/l-alpha-gpc-novel-food-efsa-opinion-formulation-opportunity-limits/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/02/l-alpha-gpc-novel-food-efsa-opinion-formulation-opportunity-limits/</guid><pubDate>Sun, 02 Aug 2026 06:00:00 GMT</pubDate><description>EFSA concluded that L-alpha-glycerylphosphorylcholine produced from soy phospholipids is safe under the proposed supplement uses.</description></item><item><title>Microalgal DHA: without conclusive strain identity, the dossier stops.</title><link>https://gmafoodintelligence.it/en/news/2026/08/02/schizochytrium-a2-dha-novel-food-strain-identity-insufficient-data/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/02/schizochytrium-a2-dha-novel-food-strain-identity-insufficient-data/</guid><pubDate>Sun, 02 Aug 2026 06:00:00 GMT</pubDate><description>EFSA could not conclude on the safety of oil from Schizochytrium sp. A2 intended for infant and follow-on formula.</description></item><item><title>EFSA’s botanical Compendium: a screening tool, not a blacklist.</title><link>https://gmafoodintelligence.it/en/news/2026/08/02/efsa-compendium-botanicals-risk-scouting-not-a-blacklist/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/02/efsa-compendium-botanicals-risk-scouting-not-a-blacklist/</guid><pubDate>Sun, 02 Aug 2026 06:00:00 GMT</pubDate><description>The EFSA database gathers plant species reported to contain substances that may be relevant to food and supplement safety.</description></item><item><title>LLMs and nutraceutical biosynthesis: from literature to candidate strains.</title><link>https://gmafoodintelligence.it/en/news/2026/08/02/llm-literature-mining-microorganisms-nutraceutical-biosynthesis-preprint/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/02/llm-literature-mining-microorganisms-nutraceutical-biosynthesis-preprint/</guid><pubDate>Sun, 02 Aug 2026 06:00:00 GMT</pubDate><description>A preprint describes a text-mining system using domain-adapted language models to extract relationships between microorganisms and nutraceutical compounds.</description></item><item><title>New micronutrient sources: EFSA updates the assessment framework.</title><link>https://gmafoodintelligence.it/en/news/2026/08/01/efsa-new-micronutrient-sources-safety-bioavailability-guidance/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/01/efsa-new-micronutrient-sources-safety-bioavailability-guidance/</guid><pubDate>Sat, 01 Aug 2026 06:00:00 GMT</pubDate><description>EFSA is updating the scientific principles and data required to assess the safety and relative bioavailability of new vitamin and mineral sources.</description></item><item><title>Emerging ingredients: EFSA surveillance becomes a scouting tool.</title><link>https://gmafoodintelligence.it/en/news/2026/08/01/efsa-emerging-ingredients-monitoring-supplements-botanicals-probiotics/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/01/efsa-emerging-ingredients-monitoring-supplements-botanicals-probiotics/</guid><pubDate>Sat, 01 Aug 2026 06:00:00 GMT</pubDate><description>The European Food Supplement Project identifies botanicals, plant substances and microorganisms that warrant closer scientific and regulatory monitoring.</description></item><item><title>AI and functional foods: from bioactive discovery to manufacturing.</title><link>https://gmafoodintelligence.it/en/news/2026/08/01/ai-functional-foods-review-bioactive-discovery-process-optimisation/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/01/ai-functional-foods-review-bioactive-discovery-process-optimisation/</guid><pubDate>Sat, 01 Aug 2026 06:00:00 GMT</pubDate><description>A Trends in Food Science &amp; Technology review maps AI applications in source and compound discovery, personalised nutrition and process efficiency.</description></item><item><title>Explainable AI: making bioactive and formulation predictions legible.</title><link>https://gmafoodintelligence.it/en/news/2026/08/01/explainable-ai-bioactive-compounds-formulation-transparency-validation/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/01/explainable-ai-bioactive-compounds-formulation-transparency-validation/</guid><pubDate>Sat, 01 Aug 2026 06:00:00 GMT</pubDate><description>A Food Chemistry: X quasi-systematic review analyses 53 studies and identifies Explainable AI as a key step in interpreting predictions for bioactive compounds and functional foods.</description></item><item><title>L-α-GPC from soy lecithin: EFSA concludes its Novel Food safety review.</title><link>https://gmafoodintelligence.it/en/news/2026/08/01/efsa-l-alpha-gpc-soy-lecithin-novel-food-safety-opinion/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/08/01/efsa-l-alpha-gpc-soy-lecithin-novel-food-safety-opinion/</guid><pubDate>Sat, 01 Aug 2026 06:00:00 GMT</pubDate><description>EFSA’s NDA Panel assessed L-alpha-glycerylphosphorylcholine made from soy phospholipids and identified no safety concern under the proposed conditions of use.</description></item><item><title>NR and pterostilbene in menopause: a pilot that helps frame the question.</title><link>https://gmafoodintelligence.it/en/news/2026/07/31/nr-pterostilbene-menopause-pilot-hypothesis-validation/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/07/31/nr-pterostilbene-menopause-pilot-hypothesis-validation/</guid><pubDate>Fri, 31 Jul 2026 06:00:00 GMT</pubDate><description>A seven-day open-label pilot in 40 women explores menopause-transition symptoms and oestrogen metabolites after nicotinamide riboside and pterostilbene.</description></item><item><title>CRL1505: building a probiotic dossier without losing the strain.</title><link>https://gmafoodintelligence.it/en/news/2026/07/31/crl1505-probiotic-dossier-strain-product-evidence/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/07/31/crl1505-probiotic-dossier-strain-product-evidence/</guid><pubDate>Fri, 31 Jul 2026 06:00:00 GMT</pubDate><description>The Lacticaseibacillus rhamnosus CRL1505 trial becomes an operational case for linking identity, dose, matrix, population and endpoints in a product dossier.</description></item><item><title>Multi-ingredient formulas: from bioavailability to proof of the finished product.</title><link>https://gmafoodintelligence.it/en/news/2026/07/31/multi-ingredient-formulations-finished-product-validation-ladder-ag1/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/07/31/multi-ingredient-formulations-finished-product-validation-ladder-ag1/</guid><pubDate>Fri, 31 Jul 2026 06:00:00 GMT</pubDate><description>The AG1 crossover study shows the first rung in a validation strategy for complex matrices: measure what reaches circulation before discussing benefit.</description></item><item><title>Generative AI attempts to turn formulation into inverse design.</title><link>https://gmafoodintelligence.it/en/news/2026/07/31/generative-ai-inverse-design-functional-food-formulation/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/07/31/generative-ai-inverse-design-functional-food-formulation/</guid><pubDate>Fri, 31 Jul 2026 06:00:00 GMT</pubDate><description>A new preprint proposes a generative science of formulation that treats nutrition, taste, sustainability, cost and manufacturability as simultaneous objectives.</description></item><item><title>Hair wellness: from a single ingredient to a biological system that needs evidence.</title><link>https://gmafoodintelligence.it/en/news/2026/07/31/hair-wellness-systems-biology-microbiome-longevity/</link><guid isPermaLink="true">https://gmafoodintelligence.it/en/news/2026/07/31/hair-wellness-systems-biology-microbiome-longevity/</guid><pubDate>Fri, 31 Jul 2026 06:00:00 GMT</pubDate><description>The hair-supplement market is moving towards microbiome, stress, hormones, cellular metabolism and healthy ageing, but concept complexity calls for more precise evidence.</description></item></channel></rss>
